Search research articles
Contact Us
Filters
Showing results (531-540 of 594) with videos related to
Page
of 60
Sort By:
Journal of Clinical Psychopharmacology
|
August 15, 2024
Prebiotic Treatment in People With Schizophrenia
Robert W Buchanan, Anne E Werkheiser, Hanna Michel, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 11, 2024
Multivariate Association Between Functional Connectivity Gradients and Cognition in Schizophrenia Spectrum Disorders
Ju-Chi Yu, Colin Hawco, Lucy Bassman, et al.
Biological Psychiatry
|
May 10, 2008
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative
Cameron S Carter, Deanna M Barch, Robert W Buchanan, et al.
Molecular Psychiatry
|
March 13, 2026
Multivariate relationships between social cognitive performance and functional connectivity during task and rest across schizophrenia spectrum disorders and healthy controls
Lindsay D Oliver, Ju-Chi Yu, Colin Hawco, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Transdiagnostic Neurobiology of Social Cognition and Individual Variability as Measured by Fractional Amplitude of Low-Frequency Fluctuation in Schizophrenia and Autism Spectrum Disorders
Soroush Bagheri, Ju-Chi Yu, Julia Gallucci, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
April 23, 2025
Transdiagnostic Neurobiology of Social Cognition and Individual Variability as Measured by Fractional Amplitude of Low-Frequency Fluctuation in Autism and Schizophrenia Spectrum Disorders
Soroush Bagheri, Ju-Chi Yu, Julia Gallucci, et al.
Schizophrenia Bulletin
|
November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting
Deanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Schizophrenia Research
|
January 13, 2015
Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms
Nina R Schooler, Robert W Buchanan, Thomas Laughren, et al.
Psychopharmacology
|
July 18, 2014
Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Christine E Marx, Jimmy Lee, Mythily Subramaniam, et al.
Biological Psychiatry
|
May 22, 2018
Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects
Joseph D Viviano, Robert W Buchanan, Navona Calarco, et al.
Page
of 60
Search research articles
Search
Showing results (531-540 of 594) with videos related to
Sort By:
Page
of 60
Journal of Clinical Psychopharmacology
|
August 15, 2024
Prebiotic Treatment in People With Schizophrenia
Robert W Buchanan, Anne E Werkheiser, Hanna Michel, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 11, 2024
Multivariate Association Between Functional Connectivity Gradients and Cognition in Schizophrenia Spectrum Disorders
Ju-Chi Yu, Colin Hawco, Lucy Bassman, et al.
Biological Psychiatry
|
May 10, 2008
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative
Cameron S Carter, Deanna M Barch, Robert W Buchanan, et al.
Molecular Psychiatry
|
March 13, 2026
Multivariate relationships between social cognitive performance and functional connectivity during task and rest across schizophrenia spectrum disorders and healthy controls
Lindsay D Oliver, Ju-Chi Yu, Colin Hawco, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Transdiagnostic Neurobiology of Social Cognition and Individual Variability as Measured by Fractional Amplitude of Low-Frequency Fluctuation in Schizophrenia and Autism Spectrum Disorders
Soroush Bagheri, Ju-Chi Yu, Julia Gallucci, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
April 23, 2025
Transdiagnostic Neurobiology of Social Cognition and Individual Variability as Measured by Fractional Amplitude of Low-Frequency Fluctuation in Autism and Schizophrenia Spectrum Disorders
Soroush Bagheri, Ju-Chi Yu, Julia Gallucci, et al.
Schizophrenia Bulletin
|
November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting
Deanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Schizophrenia Research
|
January 13, 2015
Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms
Nina R Schooler, Robert W Buchanan, Thomas Laughren, et al.
Psychopharmacology
|
July 18, 2014
Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Christine E Marx, Jimmy Lee, Mythily Subramaniam, et al.
Biological Psychiatry
|
May 22, 2018
Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects
Joseph D Viviano, Robert W Buchanan, Navona Calarco, et al.
Page
of 60